Fulminant plasmapheresis-refractory thrombotic microangiopathy associated with advanced gastric cancer

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 2, 2010, Pages 222-225

  Vasko, Radovan ^a   Koziolek, Michael ^a   Füzesi, Laszlo ^a   König, Fatima ^a   Strutz, Frank ^a   Müller, Gerhard Anton ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Gastric cancer; Plasmapheresis; Thrombotic microangiopathy; TTP

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; CREATININE; GLUCOSE; HEMOGLOBIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOPSY; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CHROMOSOME ABERRATION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE COURSE; DURA MATER; ERYTHROCYTE TRANSFUSION; FEMALE; GENE AMPLIFICATION; GENETIC ANALYSIS; HEMATEMESIS; HUMAN; HYPERTRANSAMINASEMIA; LABORATORY DIAGNOSIS; MULTIPLE ORGAN FAILURE; ONCOGENE K RAS; PLASMAPHERESIS; PRIORITY JOURNAL; SPINAL CORD METASTASIS; STOMACH ADENOCARCINOMA; SUBDURAL HEMATOMA; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; TUMOR EMBOLISM; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; FATAL OUTCOME; FEMALE; HUMANS; MULTIPLE ORGAN FAILURE; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; STOMACH NEOPLASMS; TREATMENT FAILURE;

EID: 77950200861     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00710.x     Document Type: Article

References (15)

1. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006 354 : 1927 1935.
2. Vesely SK, George JN, Lammle B et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003 102 : 60 8.
3. von Bubnoff N, Sandherr M, Schneller F, Peschel C. Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast. Am J Clin Oncol 2000 23 : 74 7.
4. Koziolek MJ, Zipfel PF, Skerka C et al. Chronic course of a hemolytic uremic syndrome caused by a deficiency of factor H-related proteins (CFHR1 and CFHR3). Kidney Int 2008 74 : 384 388.
5. Werner TL, Agarwal N, Carney HM, Rodgers GM. Management of cancer-associated thrombotic microangiopathy: what is the right approach? Am J Hematol 2007 82 : 295 298.
6. Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin Thromb Hemostas 1999 25 : 217 221.
7. Kwaan HC, Soff GA. Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 1997 34 : 159 166.
8. Coppo P, Lassoued K, Mariette X et al. Effectiveness of platelet transfusions after plasma exchange in adult thrombotic thrombocytopenic purpura: a report of two cases. Am J Hematol 2001 68 : 198 201.
9. Baliga RS, Wingo CS. Quinine induced HUS-TTP: an unusual presentation. Am J Med Sci 2003 326 : 378 380.
10. Rehberg JF, Briery CM, Hudson WT, Bofill JA, Martin JN Jr. Thrombotic thrombocytopenic purpura masquerading as hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome in late pregnancy. Obstet Gynecol 2006 108 : 817 820.
11. Chang JC, Kathula SK. Various clinical manifestations in patients with thrombotic microangiopathy. J Investig Med 2002 50 : 201 206.
12. Lesesne JB, Rothschild N, Erickson B et al. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989 7 : 781 789.
13. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and a systematic review of published cases. Oncologist 2007 12 : 11 19.
14. Kranenburg O. The KRAS oncogene: past, present, and future. Biochim Biophys Acta 2005 1756 : 81 2.
15. Weiss MM, Kuipers EJ, Postma C et al. Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol 2004 26 : 307 317.